Outcome differences in patients with advanced epithelial ovarian, primary peritoneal and fallopian tube cancers treated with and without bevacizumab

Overview of attention for article published in Gynecologic Oncology, July 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (75th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy: 1 policy source

guideline: 1 clinical guideline source

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer : Review Decision Paper

Cited by National Institute for Health and Care Excellence (NICE) on 03 Jun 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.